Precision Business Insights


Immunoassays Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

The Immunoassays Market: By Product & Service (Reagents and Kits, Analyzers, Software), Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), By Application (Infectious Diseases, Oncology, Cardiology, Endocrinology, Hematology), End User (Hospitals, Diagnostic centers, Blood Banks, Others) By Geography


Immunoassays Market


Market Outline: Immunoassays Market

An immunoassay is a biochemical test directed in IVD research centers for the identification of essence of particular particles in an answer with the utilization of an antigen or neutralizer. Immunoassay diagnostics tests have been broadly utilized for over 40 years in healing centers, analytic labs, blood donation centers, and research labs. Immunoassays have various applications in vitro diagnostics for the determination of different unending and also irresistible illnesses, forecast of sickness course, surrounding the treatment, and observing the viability of the treatment. Immunoassays are broadly utilized as a part of the existence science industry for concentrate different natural frameworks by methods for examination of various organic particles, for example, proteins, hormones, and antibodies.


Market Dynamics: Immunoassays Market 

Rising rates of chronic & infectious disease and utilization of immunoassays in Oncology are the factors moving the development of the world immunoassay advertise. Furthermore, mechanical headways and affectability, cost viability, and quick investigation offered by immunoassays supplement the development. Be that as it may, low location breaking point and execution of extract obligation by the U.S. Government are impeding the development of this market. Extending biotechnology and pharmaceutical enterprises and research center robotization and developing markets in Asia presents huge openings.


Market Scope: Immunoassays Market 

The Immunoassays Market is classified on the basis of Product & Service, Technology, Application, End User and geographical regions.

Based on Product and Service, Immunoassays Market is segmented into

  • Reagents and Kits
  • Analyzers
  • Software

Based onTechnology, Immunoassays Market is segmented into

  • Fluorescence
  • Colorimetric
  • Chemiluminescence
  • Rapid Test
  • Western Blot
  • PCR

Based on Type of Treatment, Immunoassays Market is segmented into

  • Infectious Diseases
  • Oncology
  • Cardiology
  • Endocrinology
  • Hematology

Based on End User, Immunoassays Market is segmented into

  • Hospitals
  • Clinical Laboratories
  • Others


North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Market Summary: Immunoassays Market 

Improvement of incorporated frameworks with finish mechanization for finding of viral basic changes and new popular scourges are foreseen to show critical open doors in the worldwide immunoassay showcase amid the conjecture time frame. With an ascent in solidification among indicative research facilities, test volumes are anticipated to increment. This is relied upon to support interest for more coordinated multi segment frameworks that can offer arrangements, for example, total computerized test taking care of and post process test stockpiling, information combination with lab mechanization stage, and remote access checking and control. There are couple of frameworks accessible in the market that offer these highlights. One such framework is Siemens Healthineer’s Atellica analyzer framework that was presented in 2016 and gotten FDA endorsement in 2017. Late endorsements from the U.S. FDA reflect expanding speculations from scratch players for the improvement of purpose of-mind mechanized immunoassay analyzer frameworks and the ascent popular from end-users.In September 2017, Meridian Life science Inc. propelled TRUBlock Ultra, which is a functioning immunoassay impedance blocker made by HAMA, rheumatoid factor (RH), and heterophillic antibodies (HA). In June 2017, Qiagen created QFT-Plus, which identifies inert tuberculosis disease got FDA endorsement.


Regional Analysis: Immunoassays Market 

Geographically Immunoassays Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America rules the immunoassay market attributable to the nearness of significant market players, high selection rate, and expanding commonness of irresistible sicknesses. As per the measurements recommended by the Centers for Disease Control (CDC) and Prevention, around 9,421 instances of tuberculosis, 51,455 instances of salmonella, 33,461 instances of Lyme ailment, and 433 instances of meningococcal ailment were enlisted in the United States. Europe holds the second position in the immunoassay market. It is normal that the financing gave by the legislature and private associations towards innovative work and the rising commonness of irresistible infection are probably going to drive the European market. Owing to an enormous patient pool and the expanding interest and advancement in the human services innovation, Asia Pacific is the quickest developing immunoassay market Medicinal services use is observed to enhance in different districts in the Asia Pacific. As indicated by the information recommended by the Australian Institute of Health and Welfare amid the year 2015– 16, the aggregate wellbeing consumption was USD 170.4 billion, i.e., 3.6% higher than the use of 2014– 2015. The rising instances of bladder tumor are likewise pushing the market development in the Asia Pacific area.


Market participants: Immunoassays Market 

Some of the players in Immunoassays Market

  • Abbott Laboratories (US)
  • Roche (Switzerland)
  • Siemens (Germany)
  • bioMérieux (France)
  • Sysmex Corporation (Japan)
  • Ortho Clinical Diagnostics (US)
  • QIAGEN (Netherlands)
  • DiaSorin (Italy)
  • Thermo Fisher Scientific (US)
  • Merck (Germany)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories (US)
  • PerkinElmer (US)
  • Agilent Technologies (US)
  • Bio-Techne Corporation (US)
  • Quidel Corporation (US)
  • Mindray (China)


$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
Single User $ 4,400.00
Multiple User $ 6,600.00
Corporate User $ 8,900.00
buy now spinner

Our Clients